We have located links that may give you full text access.
Synthesis and Bioactivity Characterization of Scutellarein Sulfonated Derivative.
Scutellarin ( 1 ) has been widely used to treat acute cerebral infarction in clinic, but poor aqueous solubility decreases its bioavailability. Interestingly, scutellarin ( 1 ) could be metabolized into scutellarein ( 2 ) in vivo. In this study, a sulfonic group was introduced at position C-8 of scutellarein ( 2 ) to enhance the aqueous solubility of the obtained derivative ( 3 ). DPPH (1,1-diphenyl-2-picrylhydrazyl)-radical scavenging ability and antithrombic activity were also conducted to determine its bioactivity. The result showed that scutellarein derivate ( 3 ) could be a better agent for ischemic cerebrovascular disease treatment.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app